Candesic visits Imperial College Business School
16 March 2023This week our team visited Imperial College Business School. Candesic is a leading strategy consultancy providing CEO level clarity with…Candesic announced as finalists once again- HealthInvestor Awards 2023
7 March 2023Another successful year with HealthInvestor. We salute you and thank you for announcing us as finalists for both Strategic and…We have been shortlisted!
20 February 2023We are proud to share that we have been selected as finalists in the category "Technology Due Diligence of the…Candesic hosting a roundtable to champion Genetics sector
2 February 2023This week Candesic hosted a roundtable to champion our genetics sector in a global race of discovery. Dr Michelle Tempest…Dr Michelle Tempest chairing the Royal Society of Medicine event
19 January 2023Yesterday Candesic attended the Royal Society of Medicine event to discuss digital therapeutics and the opportunities to improve patient experience and outcomes. Candesic Senior Partner…Candesic starting new year with IPEM Cannes 2023
16 January 2023Candesic is starting 2023 with appearance at IPEM Cannes conference where we will be discussing upcoming opportunities and challenges. Meet…Merry Christmas from our team!
21 December 2022Season’s greetings and holiday wishes for the new year from the very merry team at Candesic. We are wishing you…Dr Michelle Tempest visits Royal Society of Medicine
12 December 2022Senior Partner Dr Michelle Tempest at the Royal Society of Medicine discussing all things digital, healthcare and robots. The Royal…Candesic donates to Movember
7 December 2022Last month Candesic grew a Mo and proudly donated to Movember. Movember is raising awareness about biggest men health issues, providing free online…HealthInvestor Power50 awards
9 November 2022Congratulations to Dr Leonid Shapiro, Managing Partner Candesic, on being nominated for HealthInvestor Power50 awards as a sector specialist. Power50…
